Cargando…
PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis: Erratum
Autores principales: | Du, Peng, Luo, Kaifeng, Li, Guoyong, Zhu, Jisheng, Xiao, Qi, Li, Yong, Zhang, Xingjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964328/ https://www.ncbi.nlm.nih.gov/pubmed/35370468 http://dx.doi.org/10.7150/ijms.71614 |
Ejemplares similares
-
PRMT4 promotes hepatocellular carcinoma progression by activating AKT/mTOR signaling and indicates poor prognosis
por: Du, Peng, et al.
Publicado: (2021) -
Moxidectin induces Cytostatic Autophagic Cell Death of Glioma Cells through inhibiting the AKT/mTOR Signalling Pathway: Erratum
por: Liu, Jingjing, et al.
Publicado: (2023) -
Triptolide Suppresses Glomerular Mesangial Cell Proliferation in Diabetic Nephropathy Is Associated with Inhibition of PDK1/Akt/mTOR Pathway: Erratum
por: Han, Fei, et al.
Publicado: (2020) -
Erratum to PAK4-relevant proliferation reduced by cell autophagy via p53/mTOR/p-AKT signaling
Publicado: (2023) -
Activation of Akt/mTOR Pathway Is Associated with Poor Prognosis of Nasopharyngeal Carcinoma
por: Wang, Weiyuan, et al.
Publicado: (2014)